Two Indian nationals got charged with smuggling fake Ozempic from China into the United States. The DOJ dropped a criminal indictment in Florida. The counterfeit weight-loss drugs came from China. They were heading to American adults who cannot stop injecting themselves with anything that promises a smaller waistline.
GLP-1 drug use hit new highs among U.S. adults. Novo Nordisk makes the real Ozempic. Someone in China figured out how to make the fake version. Two guys in India figured out how to move it. Americans figured out how to buy mystery injections from strangers. This is called progress.
The indictment landed in Florida, which tracks. Florida stays undefeated as the staging ground for America's dumbest criminal enterprises. You want to smuggle counterfeit diabetes medication for off-label weight loss? Florida's got the infrastructure. The demand curve meets the supply chain at a strip mall in Tampa.
Retail traders saw this headline and immediately searched for Novo Nordisk's ticker. They wondered if this news meant they should buy the dip. They did not wonder what's in the counterfeit version. They did not wonder about the supply chain that runs from a factory in China through two Indian smugglers into their neighbor's refrigerator. They wondered about entry points.
The criminal complaint exists. The charges are real. The counterfeit drugs were moving. Nobody asked how many doses already made it through before the DOJ noticed. Nobody asked how many Americans injected fake Ozempic and thought it was working because they stopped eating from the placebo effect. Nobody asked because nobody wants the answer.
This changes nothing about Novo Nordisk's stock price. This changes nothing about demand for weight-loss drugs. This changes nothing about Americans willing to inject themselves with compounds of unknown origin. The only thing that changed is two guys now need a lawyer in Florida, which is the worst kind of lawyer to need.
Photo by on Unsplash
Leave a Comment